Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$6.02M Buy
41,785
+22,205
+113% +$2.72M 0.39% 70
2025
Q2
$1.97M Buy
+19,580
New +$1.5M 0.07% 287
2024
Q2
Sell
-14,298
Closed -$388K 1671
2024
Q1
$388K Buy
+14,298
New +$400K 0.01% 812

Other funds holding INSM

Point72 (DIFC)'s INSM Position: Q3 2025 in Review

Point72 (DIFC) increased its Insmed (INSM) stake by 113% in Q3 2025, buying an estimated $2.72M and bringing the position to 41,785 shares worth $6.02M. The position accounts for 0.39% of the portfolio, ranked #70.

Point72 (DIFC) first reported a position in INSM in Q1 2024 and has held it in 3 quarters since. 566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

  • Point72 (DIFC) held 41,785 shares of Insmed worth $6.02M as of Q3 2025.
  • Point72 (DIFC) bought 22,205 Insmed shares in Q3 2025, an estimated $2.72M.
  • Insmed made up 0.39% of Point72 (DIFC)'s portfolio in Q3 2025, its #70 holding.
  • Point72 (DIFC) first reported a position in Insmed in Q1 2024 and has held it in 3 quarters since.
  • 566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.